End-of-day quote
Other stock markets
|
||
- USD | - |
|
06-21 | Navidea Biopharmaceuticals, Inc. Announces Board Resignations | CI |
2023 | Navidea Biopharmaceuticals, Inc. announced that it has received $0.75 million in funding | CI |
Chart calendar Neoprobe Corporation
Upcoming events on Neoprobe Corporation
Past events on Neoprobe Corporation
2023-11-16 13:00 | Annual General Meeting |
2023-11-13 | Q3 2023 Earnings Release |
2023-07-27 13:00 | Extraordinary Shareholders Meeting |
2023-06-07 16:00 | Q1 2023 Earnings Release |
2023-03-21 17:00 | Q4 2022 Earnings Call |
2023-03-21 16:01 | Q4 2022 Earnings Release |
2022-12-08 13:00 | Annual General Meeting |
2022-11-15 17:00 | Q3 2022 Earnings Call |
2022-11-14 08:00 | Q3 2022 Earnings Release |
2022-11-10 09:00 | Annual Meeting of the Society for Immunotherapy of Cancer - Abstract #1161 |
2022-11-09 | American College of Rheumatology Convergence Conference |
2022-09-08 16:00 | Interim 2022 Earnings Call |
2022-08-15 08:30 | Interim 2022 Earnings Release |
2022-06-11 21:00 | Society of Nuclear Medicine and Molecular Imaging Meeting - Abstract No-197 |
2022-05-12 17:00 | Q1 2022 Earnings Call |
2022-05-12 07:30 | Q1 2022 Earnings Release |
2022-04-20 17:00 | NAV3-32 Phase 2B Study Results Call |
2022-04-14 17:00 | Business Update Call |
2022-03-23 17:00 | FY 2021 Earnings Call |
2022-03-23 07:30 | FY 2021 Earnings Release |
Annual results
Fiscal Period | December | 2018 | 2019 | 2020 |
---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 1,17 | 0,66 0,77 -14.18% | 0,92 0,90 2.18% |
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - |
EBIT Million USD | Released Forecast Spread | 0,00 | -11,0 -11,0 0.09% | -10,7 -12,1 11.2% |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -10,9 -11,0 0.17% | -10,7 -12,1 11.02% |
Net income Million USD | Released Forecast Spread | 0,00 | -10,9 -11,0 0.16% | -11,4 -12,1 5.51% |
EPS USD | Released Forecast Spread | -1,80 | -0,76 -0,74 -3.4% | -0,48 -0,48 0% |
Announcement Date | - | 11/03/20 | 24/03/21 |
Quarterly results
Fiscal Period | December | 2021 Q3 |
---|---|---|
Net sales Million USD | Released Forecast Spread | 0,10 0,00 - |
EBIT Million USD | Released Forecast Spread | -2,42 -3,52 31.26% |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -2,42 -3,52 31.26% |
Net income Million USD | Released Forecast Spread | -2,44 -3,52 30.8% |
EPS USD | Released Forecast Spread | -0,08 -0,11 27.27% |
Announcement Date | 10/11/21 |
2024-07-15 01:45 | ADDLIFE AB: Q2 2024 Earnings Release |
2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
2024-07-23 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-23 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
2024-07-23 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
2024-07-23 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
2024-07-24 | LONZA GROUP AG: Q2 2024 Earnings Release |
2024-07-25 01:00 | BACHEM HOLDING AG: Q2 2024 Earnings Release |
2024-07-25 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
2024-07-26 01:00 | BB BIOTECH AG: Q2 2024 Earnings Release |
Past sector events for Neoprobe Corporation
2024-06-07 02:57 | POLARIS GROUP: May 2024 Sales and Revenue Release |
2024-05-29 16:01 | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
2024-05-23 07:00 | CUREVAC N.V.: Q1 2024 Earnings Release |
2024-05-22 01:00 | EVOTEC SE: Q1 2024 Earnings Release |
2024-05-21 17:14 | ALVOTECH: Q1 2024 Earnings Release |
2024-05-21 07:00 | EXSCIENTIA PLC: Q1 2024 Earnings Release |
2024-05-17 02:00 | BIOARCTIC AB: Q1 2024 Earnings Release |
2024-05-15 16:05 | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-15 07:00 | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 | GNI GROUP LTD.: Q1 2024 Earnings Release |
- Stock Market
- Equities
- NAVB Stock
- NEOP Stock
- Calendar Neoprobe Corporation